logo-loader
viewBioLargo, Inc.

BioLargo Water launches crowdfunding campaign to get its wastewater treatment technology into poultry processing markets

The company's Advanced Oxidation System eliminates bacteria, viruses, and other pathogenic organisms from wastewater

Chickens
Nine billion chickens are processed in the US every year, the company said, which creates roughly 60 billion gallons of contaminated wastewater

BioLargo Inc (OTCMKTS:BLGO) has initiated a regulated crowdfunding operation through its subsidiary BioLargo Water Investment Group Inc (BWIG) to secure the necessary funding to launch its patented water treatment technology into the $246 million poultry processing market. 

Nine billion chickens are processed in the US every year, the company said, which creates roughly 60 billion gallons of contaminated wastewater. BioLargo’s technology can treat the polluted water, allowing for safe wastewater discharge and water reuse.

The technology is BWIG’s Advanced Oxidation System (AOS), which eliminates bacteria, viruses, and other pathogenic organisms, and can reduce pharmaceuticals and antibiotics more effectively than the standard systems used to treat wastewater. 

READ: BioLargo sets up JV with South Korea’s BKT and Tomorrow Water for CupriDyne Clean products

AOS also requires less power and is more affordable than other processes including chlorination, ozonation and UV radiation. So far it's been tested by a poultry farm in Canada, a microbrewery in Southern California and a stormwater site in Southern California.

In addition to the poultry processing market, the Westminster, Claifornia company intends to enter the $44 billion stormwater, food and beverage, oil and gas, municipal, industrial and agriculture wastewater markets.

BioLargo Water has won more than 70 grants for the development and commercialization of water treatment technology and is supported by more than 20 industry and academic collaborators.

BioLargo, the parent company, is an environmental engineering company working to deliver sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care.

Shares advanced over 11% in New York to $0.23. 

Contact Andrew Kessel at [email protected] 

Follow him on Twitter @andrew_kessel

Quick facts: BioLargo, Inc.

Price: 0.1925 USD

OTCMKTS:BLGO
Market: OTCQB
Market Cap: $34.09 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of BioLargo, Inc. named herein, including the promotion by the Company of BioLargo, Inc. in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

BioLargo completes prototype for PFAS treatment system, ready for pilot testing

BioLargo (OTCQB: BLGO) CEO Dennis Calvert Calvert joined Steve Darling from Proactive with news the company has completed manufacturing on its first prototype unit of their patented BioLargo AEC to tackle PFAS contamination. Calvert told Proactive the next step and he also told investors...

3 days, 11 hours ago

2 min read